CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT(3-4a)N(0-1)M(0)) (NCT03001596)

BACKGROUND: Neoadjuvant chemoradiation is not recommended as an approach for treatment of esophageal squamous cell carcinoma due to its significant postoperative mortality. However, it is assumed the combination of neoadjuvant chemoradiation with minimally invasive esophagectomy (MIE) may reduce pos...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Han, Tan, Lijie, Shen, Yaxing, Wang, Hao, Lin, Miao, Feng, Mingxiang, Xu, Songtao, Guo, Weigang, Qian, Cheng, Liu, Tianshu, Zeng, Zhaochong, Hou, Yingyong, Yu, Zhentao, Jiang, Hongjing, Li, Zhigang, Chen, Chun, Lian, Changhong, Du, Ming, Li, Hecheng, Xie, Deyao, Yin, Jun, Zhao, Naiqing, Wang, Qun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5490174/
https://www.ncbi.nlm.nih.gov/pubmed/28659128
http://dx.doi.org/10.1186/s12885-017-3446-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5490174/
https://www.ncbi.nlm.nih.gov/pubmed/28659128
http://dx.doi.org/10.1186/s12885-017-3446-7

Ejemplares similares